|
 Contact us regarding Vioxx; attorney consultations are free.
Jul. 2, 07: Accident Raises Safety Concerns About Chinese Tires
Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature. read more »
Jul. 2, 07: Accident Raises Safety Concerns About Chinese Tires
Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature read more »
Mar. 12, 07: Vioxx jury awards $20M to Idaho couple
Merck & Co.'s painkiller Vioxx contributed to an Idaho postal worker's heart attack, a jury in Atlantic City ruled Monday, reversing the verdict in the man's first trial and awarding him and his wife... read more »
Mar. 12, 07: Jury blames Vioxx for man's heart attack, awards $20M
Merck's former painkiller Vioxx contributed to the heart attack of an Idaho postal worker, a state jury in Atlantic City ruled Monday. The jury awarded Frederick "Mike" Humeston and his wife $20 milli... read more »
Sep. 13, 06: Merck's New Painkiller May Have Same Risks as Vioxx (Update1)
Sept. 13 (Bloomberg) -- Merck & Co.'s experimental painkiller, Arcoxia, may carry the same risk of heart attacks and strokes as Vioxx, according to an analysis of 23 studies comparing side effects of ... read more »
Sep. 13, 06: Merck's Vioxx Shown to Pose Heart and Kidney Risks
Judith Levy submits: Excerpt from our One Page Annotated Wall Street Journal Summary : Merck's Vioxx Tied to New Threat; Heart Risks Start Early in Study Summary: Two studies published online yesterd... read more »
Sep. 12, 06: Vioxx?s Risks May Be More Than Others, Studies Find
A paper published Tuesday suggests that Vioxx posed heart risks that a similar drug, Celebrex, does not. read more »
Sep. 12, 06: Studies unveil more Vioxx risk
CHICAGO (Reuters) -- Two studies offer more evidence about the dangers of some painkillers, adding kidney problems to heart concerns already raised with the drug once sold as Vioxx, researchers said o... read more »
Sep. 12, 06: Vioxx Most Dangerous Cox-2 Drug: Studies
TUESDAY, Sept. 12 (HealthDay News) -- Two studies suggest that the banned prescription painkiller Vioxx was more dangerous for users than its two cox-2 inhibitor rivals, Bextra, also withdrawn, and t... read more »
Aug. 17, 06: Vioxx Trial Verdict in Favor of Defendant Merck Vacated
Seeger Weiss LLP announces that the jury verdict rendered in favor of Merck & Co. (NYSE: MRK) in the Vioxx-related trial entitled, Humeston v. Merck, has been vacated. After hearing oral argument thi... read more »
Aug. 17, 06: Merck hit by double setback over Vioxx
Merck & Co. on Thursday suffered a double setback when a federal jury awarded $51 million to a former user of its withdrawn pain medicine Vioxx, and a New Jersey judge threw out a Vioxx verdict that ... read more »
Aug. 17, 06: Merck loses Vioxx case, told to pay $51 million
A federal jury on Thursday found that Merck & Co. Inc. was negligent and knowingly made misrepresentations about its withdrawn pain medicine Vioxx, and awarded $51 million to the plaintiff. read more »
Aug. 17, 06: New Jersey Vioxx Case Tossed
The judge in the first Vioxx case Merck won tosses the case on new evidence. read more »
Aug. 17, 06: Merck hit by double setback over Vioxx
Merck & Co. on Thursday suffered a double setback when a federal jury awarded $51 million to a former user of its withdrawn pain medicine Vioxx, and a New Jersey judge threw out a Vioxx verdict that ... read more »
Aug. 17, 06: Merck loses Vioxx case, told to pay $51 million
A federal jury on Thursday found that Merck & Co. Inc. was negligent and knowingly made misrepresentations about its withdrawn pain medicine Vioxx, and awarded $51 million to the plaintiff. read more »
Aug. 17, 06: New Jersey Vioxx Case Tossed
The judge in the first Vioxx case Merck won tosses the case on new evidence. read more »
Jun. 29, 06: Testimony: Feds not told about tests that exposed Vioxx dangers
Merck & Co. did not inform federal authorities about two clinical trials in which users of the painkiller Vioxx were more likely to die than people given a placebo, jurors in the first Vioxx liability... read more »
Jun. 26, 06: Study correction shows early Vioxx risks
A correction published Monday by a medical journal to a key study on withdrawn painkiller Vioxx reveals the risk of heart problems was elevated throughout the time people took the drug and did not de... read more »
Jun. 12, 06: Federal Trial Over Vioxx Begins Monday
A federal trial over the now-defunct drug Vioxx begins Monday in New Orleans. The case involves a New Orleans man who suffered a heart attack after taking the drug. Merck, the maker of Vioxx, is choo... read more »
Jun. 5, 06: Grandmother takes on Merck in Vioxx trial
Drug maker Merck & Co. repeatedly tried to downplay the cardiac risks of its painkiller Vioxx, so user Elaine Doherty didn't know about them and couldn't control them before she suffered a heart atta... read more »
Jun. 2, 06: Jury Chosen in N.J. for Next Vioxx Trial
A jury of five women and five men was selected Friday in Atlantic City for the seventh trial against drug maker Merck & Co. over its withdrawn arthritis drug Vioxx. read more »
May. 31, 06: FDA Whistleblower Says Agency Smeared Him Over His Vioxx Views
May 31 (Bloomberg) -- A U.S. Food and Drug Administration whistleblower who claimed Merck & Co.'s Vioxx painkiller caused 140,000 heart attacks and strokes testified that co-workers at his agency trie... read more »
May. 30, 06: Merck Admits a Data Error on Vioxx
Merck said that it erred when it reported in early 2005 that a crucial statistical test showed that Vioxx caused heart problems only after 18 months of continuous use. read more »
May. 30, 06: Merck corrects Vioxx study description, but results unchanged
Merck, the no. 2 drugmaker in America, said on Tuesday that it made a correction to the study that led to the withdrawal of its arthritis painkiller Vioxx, but that it didn't change the results of the... read more »
May. 3, 06: Canadian Vioxx study challenges Merck
A Canadian study involving thousands of Vioxx patients concluded they faced the highest risk of heart attack during the first few weeks of taking Merck's arthritis painkiller. read more »
May. 2, 06: Vioxx Heart Attacks May Occur in 2 Weeks, Study Says (Update2)
May 2 (Bloomberg) -- Merck & Co.'s Vioxx painkiller may raise the risk of a heart attack within two weeks after patients start taking the drug, earlier than previous studies have shown, according to C... read more »
Apr. 5, 06: Jury awards $4.5 mln in Vioxx verdict against Merck
Jurors in Merck & Co.'s Vioxx trial awarded $4.5 million on Wednesday to a 77-year-old New Jersey man after finding the painkiller contributed to his heart attack, casting doubts on the strategy Merc... read more »
Mar. 16, 06: Judge OKs subpoena of Vioxx critic at FDA
A government whistle-blower who criticized the Food and Drug Administration's handling of Vioxx will be deposed, giving evidence that could aid thousands of lawsuits over the withdrawn painkiller. read more »
Jan. 15, 06: More Vioxx cases for court
Two more federal lawsuits claiming the painkiller Vioxx caused heart attacks or other cardiovascular problems are scheduled for trial in the next few months. read more »
Dec. 23, 05: Federal Vioxx Retrial Set for Feb. in New Orleans
Round Two of the first U.S. federal trial challenging safety of Merck & Co.'s drug Vioxx will be Feb. 6 in New Orleans, a judge has told attorneys. U.S. District Judge Eldon Fallon of New Orleans read more »
Dec. 21, 05: Vioxx Case Indicates Need For 'Slowed' FDA Approvals Of New Medications, Op-Ed Says
The COX-2 inhibitor Vioxx, which Merck withdrew from the market in 2004 over safety concerns, "might be doing some good in limited use today, if only the FDA had slowed the approval process enough for... read more »
Dec. 19, 05: Mistrial declared in Vioxx lawsuit
In an apparent setback for Merck, a federal judge in Houston has declared a mistrial in Plunkett v. Merck, the third Vioxx lawsuit to reach trial, after jurors said they were hopelessly deadlocked. read more »
What is Vioxx?
Vioxx was marketed by Merck & Co., before it was pulled from the worldwide market. Vioxx, also known by the generic name of rofecoxib, was voluntarily withdrawn by Merck on September 30, 2004. Merck mounted a very aggressive marketing campaign for Vioxx when it was first introduced to the market, resulting in enormous revenues from the sales of the drug. In 2003, Merck enjoyed Vioxx sales of approximately $2.5 billion. An estimated 84 million people worldwide have used Vioxx since it was introduced, and Vioxx was one of the most frequently prescribed drugs in the United States. Due to the enormous popularity of Vioxx, the recall of Vioxx in 2004 was the largest drug recall in history at the time.
Contact us regarding Vioxx; attorney consultations are free.
« Back to Vioxx page
|
|
| | |
